476 research outputs found
Uganda’s HIV Prevention Success: The Role of Sexual Behavior Change and the National Response. Commentary on Green et al. (2006)
The paper by Green et al. (vol. 10, this issue
Distribution of sulfate-reducing bacteria in a stratified Fjord (Mariager Fjord, Denmark) as evaluated by most-probable-number counts and denaturing gradient gel electrophoresis of PCR-amplified ribosomal DNA fragments
The sulfate-reducing bacterial populations of a stratified marine water column, Mariager Fjord, Denmark, were investigated by molecular and culture-dependent approaches in parallel. Denaturing gradient gel electrophoresis (DGGE) of PCR-amplified 16S rRNA and DNA encoding rRNA (rDNA) isolated from the water column indicated specific bacterial populations in different water column layers and revealed a highly differentiated pattern of rRNA- and rDNA-derived PCR amplificates, probably reflecting active and resting bacterial populations. Hybridization of DGGE patterns with rRNA probes indicated the increased presence and activity (by at least 1 order of magnitude) of sulfate-reducing bacteria within and below the chemocline. Parallel to this molecular approach, an approach involving most-probable-number (MPN) counts was used, and it found a similar distribution of cultivable sulfate-reducing bacteria in the water column of Mariager Fjord, Approximately 25 cells and 250 cells per ml above and below the chemocline, respectively, were found. Desulfovibrio-and Desulfobulbus-relateA strains occurred in the oxic zone. DGGE bands from MPN cultures were sequenced and compared with those obtained from nucleic acids extracted from water column samples. The MPN isolates were phylogenetically affiliated with sulfate-reducing delta subdivision proteobacteria (members of the genera Desulfovibrio, Desulfobulbus, and Desulfobacter), whereas the molecular isolates constituted an independent lineage of the delta subdivision proteobacteria. DGGE of PCR-amplified nucleic acids with general eubacterial PCR primers conceptually revealed the general bacterial population, whereas the use of culture media allowed cultivable sulfate-reducing bacteria to be selected. A parallel study of Mariager Fjord biogeochemistry, bacterial activity, and bacterial counts complementing this investigation has been presented elsewhere (N. B. Ramsing, H. Fossing, T. G. Ferdelman, F. Andersen, and B. Thamdrup, Appl. Environ. Microbiol. 62:1391-1404, 1996)
Use of injectable hormonal contraception and women’s risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda
Background The injectable hormonal contraceptive depo-medroxyprogesterone acetate (DMPA) has been associated
with increased risk of HIV acquisition, but fi ndings are inconsistent. Whether DMPA increases the risk of other
sexually transmitted viral infections is unknown. We assessed the association between DMPA use and incident
herpes simplex virus type 2 (HSV2) infection in women.
Methods In this prospective study, we enrolled HIV-negative and HSV2-negative women aged 15–49 years whose
HIV-negative male partners were concurrently enrolled in a randomised trial of male circumcision in Rakai, Uganda.
We excluded women if either they or their male partners HIV seroconverted. The primary outcome was HSV2
seroconversion, assessed annually. The male circumcision trial was registered with ClinicalTrials.gov, number
NCT00425984.
Findings Between Aug 11, 2003, and July 6, 2006, we enrolled 682 women in this study. We noted HSV2
seroconversions in 70 (10%) women. Incidence was 13·5 per 100 person-years in women consistently using DMPA
(nine incident infections per 66·5 person-years), 4·3 per 100 person-years in pregnant women who were not using
hormonal contraception (18 incident infections per 423·5 person-years), and 6·6 per 100 person-years in women
who were neither pregnant nor using hormonal contraception (35 incident infections per 529·5 person-years).
Women consistently using DMPA had an adjusted hazard ratio for HSV2 seroconversion of 2·26 (95% CI
1·09–4·69; p=0·029) compared with women who were neither pregnant nor using hormonal contraception. Of
132 women with HSV2-seropositive partners, seroconversion was 36·4 per 100 person-years in consistent DMPA
users (four incident infections per 11 person-years) and 10·7 per 100 person-years in women who were neither
pregnant nor using hormonal contraception (11 incident infections per 103 person-years; adjusted hazard ratio
6·23, 95% CI 1·49–26·3; p=0·012).
Interpretation Consistent DMPA use might increase risk of HSV2 seroconversion; however, study power was low.
These fi ndings should be assessed in larger populations with more frequent follow-up than in this study, and other
contraceptive methods should also be assessed. Access to a wide range of highly eff ective contraceptive methods is
needed for women, particularly in sub-Saharan Africa
The Safety of Adult Male Circumcision in HIV-Infected and Uninfected Men in Rakai, Uganda
Ron Gray and colleagues report on complications of circumcision in HIV-infected and HIV-uninfected men from two related trials in Uganda, finding increased risk with intercourse before wound healing
Transmission Selects for HIV-1 Strains of Intermediate Virulence: A Modelling Approach
Recent data shows that HIV-1 is characterised by variation in viral virulence factors that is heritable between infections, which suggests that viral virulence can be naturally selected at the population level. A trade-off between transmissibility and duration of infection appears to favour viruses of intermediate virulence. We developed a mathematical model to simulate the dynamics of putative viral genotypes that differ in their virulence. As a proxy for virulence, we use set-point viral load (SPVL), which is the steady density of viral particles in blood during asymptomatic infection. Mutation, the dependency of survival and transmissibility on SPVL, and host effects were incorporated into the model. The model was fitted to data to estimate unknown parameters, and was found to fit existing data well. The maximum likelihood estimates of the parameters produced a model in which SPVL converged from any initial conditions to observed values within 100–150 years of first emergence of HIV-1. We estimated the 1) host effect and 2) the extent to which the viral virulence genotype mutates from one infection to the next, and found a trade-off between these two parameters in explaining the variation in SPVL. The model confirms that evolution of virulence towards intermediate levels is sufficiently rapid for it to have happened in the early stages of the HIV epidemic, and confirms that existing viral loads are nearly optimal given the assumed constraints on evolution. The model provides a useful framework under which to examine the future evolution of HIV-1 virulence
Recommended from our members
Traditional Herbal Medicine Use Associated with Liver Fibrosis in Rural Rakai, Uganda
Background: Traditional herbal medicines are commonly used in sub-Saharan Africa and some herbs are known to be hepatotoxic. However little is known about the effect of herbal medicines on liver disease in sub-Saharan Africa. Methods: 500 HIV-infected participants in a rural HIV care program in Rakai, Uganda, were frequency matched to 500 HIV-uninfected participants. Participants were asked about traditional herbal medicine use and assessed for other potential risk factors for liver disease. All participants underwent transient elastography (FibroScan®) to quantify liver fibrosis. The association between herb use and significant liver fibrosis was measured with adjusted prevalence risk ratios (adjPRR) and 95% confidence intervals (CI) using modified Poisson multivariable logistic regression. Results: 19 unique herbs from 13 plant families were used by 42/1000 of all participants, including 9/500 HIV-infected participants. The three most-used plant families were Asteraceae, Fabaceae, and Lamiaceae. Among all participants, use of any herb (adjPRR = 2.2, 95% CI 1.3–3.5, p = 0.002), herbs from the Asteraceae family (adjPRR = 5.0, 95% CI 2.9–8.7, p<0.001), and herbs from the Lamiaceae family (adjPRR = 3.4, 95% CI 1.2–9.2, p = 0.017) were associated with significant liver fibrosis. Among HIV infected participants, use of any herb (adjPRR = 2.3, 95% CI 1.0–5.0, p = 0.044) and use of herbs from the Asteraceae family (adjPRR = 5.0, 95% CI 1.7–14.7, p = 0.004) were associated with increased liver fibrosis. Conclusions: Traditional herbal medicine use was independently associated with a substantial increase in significant liver fibrosis in both HIV-infected and HIV-uninfected study participants. Pharmacokinetic and prospective clinical studies are needed to inform herb safety recommendations in sub-Saharan Africa. Counseling about herb use should be part of routine health counseling and counseling of HIV-infected persons in Uganda
- …